Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

RAPID-2. A Study to Evaluate the Effectiveness of Alternate Dosing of PROCRIT (Epoetin Alfa) in Maintaining Hemoglobin Levels in Patients With Chemotherapy Related Anemia

This study has been terminated.
(This study was stopped due to slow enrollment after enrolling 25 of 200 patients.)
Information provided by:
Ortho Biotech, Inc. Identifier:
First received: June 29, 2007
Last updated: July 2, 2007
Last verified: June 2007
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2003
  Estimated Primary Completion Date: No date given